<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://www.medsurfnews.com</link><description>Le ultime risorse da Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthware.it</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://www.medsurfnews.com/images/logo.jpg</url><link>http://www.medsurfnews.com</link></image>
	
	
	
<item>
<category>Epatologia</category>
<title>New biomarker to identify hepatitis B-infected patients at risk for liver cancer</title>
<link>http://www.medsurfnews.com/contents/it/7193/display/new-biomarker-to-identify-hepatitis-b-infected-patients-at-risk-for-liver-cancer.aspx</link>
<description><![CDATA[Hepatitis B-infected patients with significantly longer telomeres were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012. A strong correlation between telomere length and non-cirrhotic hepatocellular carcinoma (HCC), a liver cancer commonly caused from hepatitis B and C viral infections, could help physicians better stratify the hepatitis B population in an effort to better prevent and treat the disease.



]]></description>
<pubDate>Tue, 10 Apr 2012 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Choline-Poor Diet in Older Women Linked to Worse Damage from Fatty Liver Disease</title>
<link>http://www.medsurfnews.com/contents/it/7094/display/choline-poor-diet-in-older-women-linked-to-worse-damage-from-fatty-liver-disease.aspx</link>
<description><![CDATA[Menopausal women with non-alcoholic fatty liver disease (NAFLD) who don’t consume enough of the essential nutrient choline appear to be at higher risk for liver scarring, according to research led by scientists at Johns Hopkins Children’s Center.  The findings of a multicenter study  compared liver damage and choline consumption among 664 children and adults with NAFLD.]]></description>
<pubDate>Mon, 27 Feb 2012 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Prevention of Esophageal Varices Rupture</title>
<link>http://www.medsurfnews.com/contents/it/6955/display/prevention-of-esophageal-varices-rupture.aspx</link>
<description><![CDATA[Guidelines recommend the use of a beta-blocker or an endoscopic ligation in order to prevent the risk of the first bleeding due to the rupture of esophageal varices in liver cirrhosis, while, for the prevention of relapses, the association of ligation with beta-blocker has been more effective than beta-blocker alone. Now, the use of the drug alone has been compared with the combined therapy also in the prevention of the first bleeding episode. ]]></description>
<pubDate>Mon, 9 Jan 2012 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Acute-on-chronic liver failure - linking the gut, liver and systemic circulation</title>
<link>http://www.medsurfnews.com/contents/it/6820/display/acute-on-chronic-liver-failure---linking-the-gut-liver-and-systemic-circulation.aspx</link>
<description><![CDATA[This review article focuses on potentially relevant pathophysiological elements in the development of ACLF and points out some promising treatment modalities in ACLF. ]]></description>
<pubDate>Tue, 25 Oct 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Pioglitazone and Vitamin E in NASH</title>
<link>http://www.medsurfnews.com/contents/it/6506/display/pioglitazone-and-vitamin-e-in-nash.aspx</link>
<description><![CDATA[We have not got a specific therapy for non-alcoholic steatohepatitis (NASH), since there are many trials on various substances, but most of them are not randomized or they have been too short or with endpoints of unclear efficacy. Now, a phase-III, multicentric, double-blinded trial has been performed on 247 non-diabetic patients affected by NASH and randomized to receive pioglitazone (30 mg/die), vitamin E (800 UI/die) or placebo, for an overall of 96 weeks.]]></description>
<pubDate>Mon, 6 Jun 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Overweight and Liver Risks</title>
<link>http://www.medsurfnews.com/contents/it/6343/display/overweight-and-liver-risks.aspx</link>
<description><![CDATA[From previous trials, we know that the presence of overweight can imply even severe risks for the liver, but the interaction between overweight and alcohol intake is not completely cleared up yet, so some answers to this situation are searched. In a retrospective trial performed in Scotland, 9600 males (averagely 47 years of age at the enrolment in the trial) have been examined and fol-lowed for about thirty years. After adjustments for multiple factors it was seen that deaths for liver causes are significantly associated with both an increase in alcohol intake and an increase in BMI.]]></description>
<pubDate>Mon, 11 Apr 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Alcohol and Non-Alcoholic Steatohepatitis</title>
<link>http://www.medsurfnews.com/contents/it/6344/display/alcohol-and-non-alcoholic-steatohepatitis.aspx</link>
<description><![CDATA[Some patients affected by non-alcoholic steatohepatitis (NASH) present other clinical conditions (hyperlipidemia, diabetes) for which a moderate alcohol intake implies some benefits, but we know which are the effects of a moderate intake of small amounts of alcohol on NASH, a clinical entity with an extremely varied prognosis. In order to clear the problem up, 20 rats with a highly lipid diet (71% of the energy received by fats) up to NASH onset. Rats have been then fed with a less fat diet (55% of the energy from lipids). In 10 rats, this second diet has been modified so that 16% of calories were given by alcohol. ]]></description>
<pubDate>Mon, 11 Apr 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Treatment of Alcoholic Liver Disease</title>
<link>http://www.medsurfnews.com/contents/it/6339/display/treatment-of-alcoholic-liver-disease.aspx</link>
<description><![CDATA[Alcoholic liver disease (ALD) remains a major cause of liver-related mortality in the US and worldwide. The correct diagnosis of ALD can usually be made on a clinical basis in conjunction with blood tests, and a liver biopsy is not usually required. Abstinence is the hallmark of therapy for ALD, and nutritional therapy is the first line of therapeutic intervention. The role of steroids in patients with moderate to severe alcoholic hepatitis is gaining increasing acceptance, with the caveat that patients be evaluated for the effectiveness of therapy at 1 week. Pentoxifylline appears to be especially effective in ALD patients with renal dysfunction/hepatorenal syndrome. Biologics such as specific anti-TNFs have been disappointing and should probably not be used outside of the clinical trial setting. Transplantation is effective in patients with end-stage ALD who have stopped drinking (usually for ≥6 months), and both long-term graft and patient survival are excellent.

]]></description>
<pubDate>Mon, 4 Apr 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia</title>
<link>http://www.medsurfnews.com/contents/it/6229/display/serum-adiponectin-and-transient-elastography-as-non-invasive-markers-for-postoperative-biliary-atresia.aspx</link>
<description><![CDATA[Biliary atresia (BA) is a progressive inflammatory disorder of the extrahepatic bile ducts leading to the obliteration of bile flow. A study determines serum adiponectin in BA patients and to investigate the relationship of adiponectin with clinical parameters and liver stiffness scores. Results showed that serum adiponectin and liver stiffness values were higher in BA patients compared with normal participants. The elevated serum adiponectin levels also positively correlated with the degree of hepatic dysfunction and liver fibrosis. Accordingly, serum adiponectin and transient elastography could serve as the useful non-invasive biomarkers for monitoring the severity and progression in postoperative BA.
]]></description>
<pubDate>Tue, 1 Mar 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Epatologia</category>
<title>Normal Values of ALT</title>
<link>http://www.medsurfnews.com/contents/it/5850/display/normal-values-of-alt.aspx</link>
<description><![CDATA[It is normal to see very variable limits in the normality range as to the values of transaminases, according to the laboratory performing the exam, and this variability often creates some problems to the patient and to the general practitioner, since an increase in this parameter could mean a liver damage. In order to verify the reason of these differences, 67 laboratories in Indiana have been examined: the upper limit ranges from 31 U/l to 72 U/l, with mild differences between men and women.]]></description>
<pubDate>Thu, 14 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	</channel></rss>
	



